YCM
ZVSA

Yakira Capital Management’s ZyVersa Therapeutics ZVSA Stock Holding History

Yakira Capital Management’s Portfolio ZVSA Stock Details ZVSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,580
Closed -$5.53M – 404
2022
Q3 		$5.53M Buy
+1,580
New +$5.52M 0.81% 32

Other funds holding ZVSA

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return

Yakira Capital Management's ZVSA Position: Q4 2022 in Review

Yakira Capital Management sold out of ZyVersa Therapeutics (ZVSA) in Q4 2022, closing a stake of 1,580 shares — an estimated $5.53M sold.

Yakira Capital Management first reported a position in ZVSA in Q3 2022 and held it in 1 quarter. The position peaked at $5.53M in Q3 2022. 2 funds tracked by Wall St. Rank hold ZVSA as of Q4 2022.

  • Yakira Capital Management reported no remaining ZyVersa Therapeutics position as of Q4 2022 after selling out during the quarter.
  • Yakira Capital Management sold 1,580 ZyVersa Therapeutics shares in Q4 2022, an estimated $5.53M.
  • Yakira Capital Management first reported a position in ZyVersa Therapeutics in Q3 2022 and held it in 1 quarter.
  • Yakira Capital Management's ZyVersa Therapeutics position peaked at $5.53M in Q3 2022.
  • 2 funds tracked by Wall St. Rank held ZyVersa Therapeutics as of Q4 2022.

Based on Yakira Capital Management's 13F filing for Q4 2022, filed 10 Feb 2023.